| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
76.54(M) |
| Last
Volume: |
3,709,408 |
Avg
Vol: |
3,188,549 |
| 52
Week Range: |
$0.1356 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-16 |
5 |
S |
$1.23 |
$643 |
I/I |
(523) |
125,877 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-15 |
5 |
S |
$1.32 |
$4,092 |
I/I |
(3,100) |
126,400 |
|
- |
|
| Allen Corrine |
Chief Financial Officer |
• • • |
2010-09-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
81,000 |
1,038,071 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-08-06 |
5 |
S |
$1.45 |
$22,475 |
I/I |
(15,500) |
129,500 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-07-09 |
5 |
S |
$0.85 |
$4,250 |
I/I |
(5,000) |
145,000 |
|
- |
|
| Van Ness Kenneth |
Director |
– • – |
2010-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,584,241 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-15 |
5 |
S |
$1.30 |
$3,770 |
I/I |
(2,900) |
150,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-14 |
5 |
S |
$1.35 |
$1,350 |
I/I |
(1,000) |
152,900 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-10 |
5 |
S |
$1.40 |
$3,640 |
I/I |
(2,600) |
153,900 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-09 |
5 |
S |
$1.30 |
$3,900 |
I/I |
(3,000) |
156,500 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-08 |
5 |
S |
$1.33 |
$9,975 |
I/I |
(7,500) |
159,500 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-03 |
5 |
S |
$1.40 |
$4,200 |
I/I |
(3,000) |
167,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-02 |
5 |
S |
$1.30 |
$2,600 |
I/I |
(2,000) |
170,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-06-01 |
5 |
S |
$1.31 |
$3,275 |
I/I |
(2,500) |
172,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-05-28 |
5 |
S |
$1.45 |
$1,450 |
I/I |
(1,000) |
174,500 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-05-26 |
5 |
S |
$1.50 |
$4,500 |
I/I |
(3,000) |
175,500 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-05-25 |
5 |
S |
$1.45 |
$725 |
I/I |
(500) |
178,500 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-05-24 |
5 |
S |
$1.45 |
$4,350 |
I/I |
(3,000) |
179,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-05-01 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
59,100 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-04-28 |
5 |
S |
$1.90 |
$3,800 |
I/I |
(2,000) |
182,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-04-22 |
5 |
S |
$1.85 |
$5,550 |
I/I |
(3,000) |
184,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-04-20 |
5 |
S |
$1.95 |
$5,850 |
I/I |
(3,000) |
187,000 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-02-25 |
5 |
S |
$2.00 |
$4,000 |
I/I |
(2,000) |
190,000 |
|
- |
|
| Van Ness Kenneth |
CEO & President |
• • • |
2010-01-15 |
4 |
S |
$1.93 |
$579 |
I/I |
(300) |
1,929,041 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-01-13 |
5 |
S |
$1.95 |
$19,500 |
I/I |
(10,000) |
192,000 |
|
- |
|
381 Records found
|
|
Page 10 of 16 |
|
|
